Month: July 2021

PALM BEACH, Fla., July 15, 2021 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), one of the nation’s fastest-growing premium fast-casual concepts, has appointed Vivian Lopez-Blanco to its board of directors, effective July 14, 2021. Lopez-Blanco’s appointment follows the sudden passing of board member Steven Berrard announced on June 10, 2021. Lopez-Blanco has also been named as the chair of the audit committee and will be serving on the compensation committee and nominating governance committee. Lopez-Blanco is an experienced board member and seasoned finance executive with expertise in organizational transformations and driving profitable growth. Currently, she serves as a board member of Jumptuit Health, Inc. and previously served as an advisory board member of BBVA, South Florida...

  ●  Revenue Grew 50% to $456,219 Compared to Q1 2021  ●  Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021  ●  Strengthening of Company Financial Position and Strategic RelationshipsWest Palm Beach, FL, July 15, 2021 (GLOBE NEWSWIRE) — USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced preliminary second quarter financial results for the period ended June 30, 2021, reporting strong sequential growth on several fronts. In the second quarter of 2021, revenue increased 49.9% sequentially to approximately $456,219 compared to first quarter 2021. Gross profit increased 55.5% sequentially to $207,717 or a 45.5% gross margin in second quarter 2021 compared to $133,579 of gross profit or a 43.9% gross margin in first quarter...

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — Probe Metals Inc. (TSX-V: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is pleased to announce the filing of a technical report for its Val-d’Or East project (the “Report“) entitled, “NI 43-101 Technical Report for the Val-d’Or East Project, Abitibi Greenstone Belt, Quebec, Canada”. The Report dated July 14th , prepared in accordance with National Instrument 43-101 (“NI 43-101”) is available for review on both SEDAR (www.sedar.com) and the Company’s website (www.probemetals.com). The Resource Estimate, which is the subject of the NI 43-101 Report, forms the basis of the Project’s upcoming Preliminary Economic Assessment (“PEA”). Upon further review of underground resource shapes the PEA and Resource consultants, Ausenco Engineering Canada Inc. (“Ausenco”) (PEA) and GoldMinds Geoservices...

AUSTIN, Texas, July 15, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult to treat cancers, announced that the Company will report second quarter 2021 financial results on Thursday, July 22, 2021, after market close. Plus Therapeutics’ management team will then host a conference call and webcast at 5:00 p.m. ET to discuss the financial results and provide a corporate update. A live webcast will be available at ir.plustherapeutics.com/events    Please refer to the information below for conference call dial-in information. Callers should dial in approximately 10 minutes prior to the start of the call.Conference dial-in: 877-876-9174International dial-in: 785-424-1669Conference ID: PSTVQ221Conference...

FREMONT, Calif., July 15, 2021 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”), the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced a contract award with General Technical Services under DOTC-17-01-INIT1218 Advanced Power Systems Technologies with the Department of Defense to demonstrate safe and efficient advanced lithium-ion battery technology to the U.S. Army. This contract was awarded in conjunction with Inventus Power, a leading provider of advanced battery and power systems that specializes in the design and manufacture of Li-ion battery packs, smart chargers, and efficient power supplies. The application for the Enovix batteries is the WarFighter centralized power source, used to power worn and carried equipment within the soldier ensemble. Enovix believes that...

Table 1Production HighlightsFigure 1Zinc ProductionTable 2ESM Production and Cost Guidance H2 ’21Figure 2Plan View of ESM Mineralized ZonesFigure 3Cross-section of Little York Mineralization (Looking NE)VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI) (“Titan” or the “Company”) today provided an update on its surface exploration drilling program and the discovery of Little York, set H2/21 production guidance for its 100% owned Empire State Mine (“ESM”) located in upstate New York, and announces an inaugural dividend. Highlights:Discovery of Little York – drilling included 11 ft of 18.4% zinc within 20 ft of 11% zinc; 4 ft of 25% zinc within 7.6 ft of 15.4% zinc ESM H2/21 production...

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — Toromont Industries Ltd. (TSX:TIH) today announces that after 36 years of dedicated service (34 as Chairman and 20 as CEO), Mr. Robert M. Ogilvie will retire as both Chairman and Director of the Board of Directors effective July 15, 2021. Mr. Ogilvie’s chairmanship extended beyond the originally scheduled retirement date of April 2021 as the COVID crisis presented unprecedented uncertainties. The company has navigated well over the last 16 months, building on a strong foundation through operational excellence and strategic execution. Given the company’s solid position, and Mr. Ogilvie’s belief that Toromont is well positioned for the future, he has advised the Board it is now an appropriate time to retire. During Mr. Ogilvie’s distinguished career, Toromont built a market-leading business...

MENLO PARK, Calif and BOSTON, July 15, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the formation of a Scientific Advisory Board (SAB). The SAB is comprised of renowned scientific leaders in the fields of T cell biology, immunology, and oncology. “We are very pleased to have such distinguished and talented experts join Adicet’s scientific advisory board,” said Chen Schor, President and Chief Executive Officer of Adicet Bio. “The combined knowledge of our SAB members in translational science and clinical development as well as their strategic counsel will serve as a vital resource in advancing the development of our lead asset, ADI-001, and our pipeline of “off-the-shelf” gamma...